Top HHS of­fi­cial Chris Klomp had a rel­a­tive­ly mild nom­i­na­tion hear­ing with sen­a­tors on Tues­day, but he sparred with Sen. Eliz­a­beth War­ren (D-MA) over vol­un­tary...

For the first time, No­var­tis’ lead­er­ship in the ra­di­oli­gand field will be test­ed by a gener­ic ri­val.

Curi­um an­nounced on Mon­day that the FDA has...

Cen­tric Com­pound­ing is un­der­go­ing a na­tion­wide re­call of three in­jectable drugs over con­t­a­m­i­na­tion is­sues with an ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API).

Three lots of the Hous­ton-based...

As the FDA ramps up its ef­fort to ac­cel­er­ate the de­vel­op­ment of psy­che­del­ic ther­a­pies, men­tal health ex­perts on Mon­day urged the agency to con­sid­er cer­tain...

The FDA’s long-await­ed ex­pe­dit­ed in­ves­ti­ga­tion­al new drug pi­lot pro­gram be­gan ac­cept­ing ap­pli­ca­tions Tues­day, with top agency of­fi­cials in­cor­po­rat­ing pub­lic feed­back in­to who should qual­i­fy.

Karim...

Ve­ra Ther­a­peu­tics said two-year da­ta show its re­cent­ly ap­proved drug Tru­tak­na sta­bi­lized kid­ney func­tion in pa­tients with a chron­ic au­toim­mune dis­ease, set­ting the drug up for...